Inventor profile of:

David Monteith

City:

Pittstown, New Jersey

Country:

United States

Published Applications:

14

Last publication date:

2018-06-07

Top Assignees for applications by David Monteith

The entities that hold a legal rights for patent applications filed by inventor Monteith David:

Recent patent applications by Monteith David

David Monteith from Pittstown, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-06-07
US20180154000A1
Human necessities

Sustained release formulation and tablets prepared therefrom

#2 | 2016-01-28
US20160024092A1
Chemistry; metallurgy

INTRAVENOUS FORMULATIONS OF NEUROKININ-1 ANTAGONISTS

#3 | 2015-10-15
US20150290147A1
Human necessities

PHENYLEPHRINE PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR COLONIC ABOSORPTION

#4 | 2015-09-24
US20150265715A1
Human necessities

Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin

#5 | 2013-04-18
US20130096053A1
Human necessities

Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin

#6 | 2012-01-26
US20120022032A1
Human necessities

CORTICOSTEROID COMPOSITIONS AND METHODS OF TREATMENTS THEREOF

#7 | 2011-02-17
US20110038925A1
Chemistry; metallurgy

Intravenous formulations of neurokinin-1 antagonists

#8 | 2010-04-01
US20100081672A1
Human necessities

PH SENSITIVE MATRIX FORMULATION

#9 | 2009-11-12
US20090280160A1
Human necessities

PHENYLEPHRINE PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR TRANSMUCOSAL ABSORPTION

#10 | 2008-06-26
US20080152712A1
Human necessities

RAPIDLY DISINTEGRATING LYOPHILIZED ORAL FORMULATIONS OF A THROMBIN RECEPTOR ANTAGONIST

#11 | 2008-01-24
US20080020055A1
Human necessities

Phenylephrine pharmaceutical formulations and compositions for colonic absorption

#12 | 2007-10-11
US20070237818A1
Human necessities

Controlled-release formulation of HCV protease inhibitor and methods using the same

#13 | 2007-05-31
US20070122355A1
Human necessities

RAPIDLY ABSORBING ORAL FORMULATIONS OF PDE 5 INHIBITORS

#14 | 2007-02-08
US20070031349A1
Human necessities

Rapidly absorbing oral formulations of PDE 5 inhibitors

InventorID:

198702 ⎘